Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Hadassah Medical Organization |
---|---|
Information provided by: | Hadassah Medical Organization |
ClinicalTrials.gov Identifier: | NCT00674141 |
The study aims to assess the safety and efficacy of nasale administration of Dexamethasone in relapsing MS patients
Condition | Intervention | Phase |
---|---|---|
MS Patient With Relpasing Remitting Attacks |
Drug: Dexamethasone soduim phosphate |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Nasal Administration of Dexamethasone for MS Treatment |
Estimated Enrollment: | 10 |
Study Start Date: | July 2008 |
Estimated Study Completion Date: | January 2009 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1
only one experimental treated group
|
Drug: Dexamethasone soduim phosphate
nasale administation of Dexamethasone in 20mg dose/day (in two divided doses) fpr sevem days of treatment
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Israel | |
Hadassah Medical Organization | |
Jerusalem, Israel, 91120 |
Principal Investigator: | Elka Touitou, PhD, Prof. | Hebrew University, Jerusalem. Israel |
Responsible Party: | Hadassah Medical Organization ( Prof. Dminitrios Karussis ) |
Study ID Numbers: | MS089-HMO-CTIL |
Study First Received: | May 6, 2008 |
Last Updated: | May 6, 2008 |
ClinicalTrials.gov Identifier: | NCT00674141 |
Health Authority: | Israel: Ministry of Health |
Multiple Sclerosis, relapsing remitting, Dexamethasone |
Dexamethasone Autoimmune Diseases Multiple Sclerosis Demyelinating Diseases Demyelinating Autoimmune Diseases, CNS |
Demyelinating diseases Sclerosis Multiple Sclerosis, Relapsing-Remitting Dexamethasone acetate Autoimmune Diseases of the Nervous System |
Anti-Inflammatory Agents Antineoplastic Agents, Hormonal Immune System Diseases Antineoplastic Agents Nervous System Diseases Physiological Effects of Drugs Gastrointestinal Agents Hormones, Hormone Substitutes, and Hormone Antagonists |
Antiemetics Glucocorticoids Hormones Pharmacologic Actions Autonomic Agents Therapeutic Uses Peripheral Nervous System Agents Central Nervous System Agents |